U.S. Leads the Global Mechanical Ventilators Market with an Estimated Value of $6.3 Billion in 2022, China Shows Rapid Growth with an 8.5% CAGR

The “Mechanical Ventilators – Global Strategic Business Report” report has been added to ResearchAndMarkets.com’s offering.

The global market for Mechanical Ventilators, valued at US$14.9 billion in 2022, is projected to experience substantial growth, reaching a size of US$22.8 billion by 2030, with a compound annual growth rate (CAGR) of 5.4% during the analysis period of 2022-2030. This growth is attributed to the rising demand for intensive care and portable/transportable ventilators.

Key Findings from the Report:

  1. Intensive Care Segment to Grow at 4.9% CAGR: The intensive care segment is expected to record a 4.9% CAGR, reaching US$15.9 billion by the end of the analysis period. This growth is fueled by the increasing need for advanced life support systems in critical care settings.
  2. Strong Growth in the Portable/Transportable Segment: The portable/transportable segment is estimated to grow at a robust CAGR of 6.7% over the next eight years. This growth is driven by the demand for ventilators that provide mobility and flexibility for patient care.
  3. U.S. Market Estimated at $6.3 Billion: The Mechanical Ventilators market in the United States is estimated to be valued at US$6.3 billion in 2022. This significant market size is due to the country’s advanced healthcare infrastructure and continuous technological advancements.
  4. China’s Rapid Growth: China, the world’s second-largest economy, is forecast to experience impressive growth with a projected market size of US$1.9 billion by 2030, showcasing a CAGR of 8.5% during the analysis period. This growth is indicative of China’s increasing investment in healthcare.
  5. Global Competitive Landscape: The report features 82 key competitors in the Mechanical Ventilators market, including industry leaders such as GE HealthCare PLC, Dragerwerk AG & Co. KGaA, and Getinge AB (Getinge Group).

Economic Outlook:

The global economic outlook is showing signs of improvement, with recovery expected in the coming years. Despite challenges such as uncertainty related to the war in Ukraine and persistent inflation in developing countries, governments are making efforts to stabilize their economies. New technologies, including generative AI, applied AI, and renewables, are expected to drive economic growth and value to global GDP.

What`s New?

  • Special discussions on the global economic climate and market sentiment
  • Coverage on global competitiveness and key competitor percentage market shares
  • Market presence analysis across multiple geographies – Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and trademarked research platform
  • Complimentary updates for one year
  • Access to curated YouTube video transcripts of market sentiments shared by CEOs, domain experts and market influencers via interviews, podcasts, press statements and event keynotes

Key Topics Covered:

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
  • All Hands On Deck: The World is Scaling Up to Meet a Multifold Rise in Ventilator Demand
  • Global Number of Infections & Patients Requiring Ventilator Support
  • Amidst the COVID-19 Pandemic, Regulatory Bodies Ease Approval Process for Ventilators
  • Concerns Rise Side Effects of Using Ventilator Usage in COVID-19 Patients
  • Mechanical Ventilators: An Introduction
  • Evolution of Mechanical Ventilators: A Historical Fact File
  • Outlook
  • US Leads the Global Mechanical Ventilators Market
  • High Unmet Medical Needs Drive Developing Nations
  • Cost Benefits to Surge Growth of Non-Invasive Ventilators
  • HomeCare Ventilation Amid Rising Healthcare Costs
  • Rise in Popularity of Portable Ventilators
  • Ways to Leverage Market Potential
  • Key Market Challenges
  • Global Healthcare Spending: A Review
  • Global Healthcare Expenditure (In US$ Trillion) for the Years 2017, 2019, and 2022
  • Mechanical Ventilators – Global Key Competitors Percentage Market Share in 2022 (E)
  • Recent Market Activity
  • Competitive Market Presence – Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

  • Technological Advancements Sustain Future Market Growth
  • Select Recent Innovations
  • Automation-Enabled Innovation Continues in Mechanical Ventilators Market
  • Auto Manufacturers Join the Race to Build Ventilators
  • Startups Intensify Efforts to Develop Low Cost Ventilators amidst COVID-19 Crisis
  • Mounting Cases of COVID-19 Infections Prompt Researchers to Explore New Approaches to Reduce Need for Ventilator Assistance
  • Major Risk Factors Creating Need for Ventilation Support for COVID-19 Patients
  • Increasing Prevalence of Chronic Respiratory Diseases Drive Growth
  • Global Prevalence of COPD by Age Group: Percentage of Men and Women Affected by the Condition
  • Neonatal Ventilators Market Set for Healthy Growth
  • Global New Births (in Millions) per Annum by Geographic Region
  • Rising Incidence of Neonatal Mortality Rates to Drive Penetration Developing Countries
  • Worldwide Neonatal Mortality Rate Estimates by Region: 2000, 2005, 2020, 2015, 2019
  • Neonatal Non-Invasive Ventilation: On the Rise
  • Lung Injury: A Major Challenge for Neonatal Ventilators Market
  • Ventilator Associated Pneumonia (VAP): A Major Menace
  • Manufacturers Introduce New Features to Tackle Enduring Issue of Alarm Fatigue
  • Advances in Information Technology Enhance Monitoring Multiple Patients on Ventilation
  • High Potential for Automatic Transport Ventilators
  • Adaptive Support Ventilation: At the Forefront of Innovation
  • Aging Population: A Key Demographic Driver
  • Global Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
  • RESPIRATORY CONDITIONS REQUIRING MECHANICAL VENTILATORS
  • Acute Respiratory Distress Syndrome
  • Chronic Obstructive Pulmonary Disease
  • Muscular Degenerative Disease
  • Spinal Cord Injury
  • Pneumonia
  • Cystic Fibrosis
  • Asthma

4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS

IV. COMPETITION

For more information about this report visit here.

Hot this week

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMedâ„¢ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.